Literature DB >> 8134557

Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection.

C Bartolozzi1, R Lencioni, D Caramella, F Falaschi, R Cioni, G DiCoscio.   

Abstract

PURPOSE: To investigate the reliability of computed tomography (CT) and magnetic resonance (MR) imaging in the evaluation of the response of hepatocellular carcinoma (HCC) to transcatheter arterial embolization (TAE) followed by percutaneous ethanol injection (PEI).
MATERIAL AND METHODS: Between January 1991 and November 1992, 20 patients (15 men and five women, aged 53-73 years [mean, 64.6 years]) with 31 HCC lesions underwent CT and MR imaging before and after treatment with combined TAE and PEI.
RESULTS: Twenty-seven tumors, which were hypointense on post-treatment T2-weighted images and on gadolinium-enhanced T1-weighted images, were seen to be necrotic at biopsy. In four cases of incomplete necrosis, viable tumor was hyperintense on T2-weighted images and was enhanced after administration of contrast material. CT provided a larger spectrum of imaging features as a result of the presence of both hyperattenuating areas (caused by retention of iodized oil) and hypoattenuating areas (due to ethanol-induced necrosis).
CONCLUSION: CT and MR imaging findings proved useful in the evaluation of the response of HCC to combined TAE and PEI.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134557     DOI: 10.1148/radiology.191.1.8134557

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.

Authors:  Toshihide Shima; Masayuki Mizuno; Hideaki Otsuji; Chiemi Mizuno; Hirozumi Obata; Hyohun Park; Shinobu Nakajo; Takeshi Okanoue
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

3.  Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.

Authors:  Yan Ling Wen; Masatoshi Kudo; Yasunori Minami; Hobyung Chung; Yoichiro Suetomi; Hirokazu Onda; Masayuki Kitano; Toshihiko Kawasaki; Kiyoshi Maekawa
Journal:  J Med Ultrason (2001)       Date:  2003-09       Impact factor: 1.314

4.  Breath-hold spin-echo MR imaging for evaluation of dynamic enhancement of native and treated hepatocellular carcinoma after intravenous Gd-DTPA administration.

Authors:  R Lencioni; M Mascalchi; A Paolicchi; V Zampa
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

5.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 6.  The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Authors:  Sung Wook Shin
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

7.  The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.

Authors:  Youn Zoo Cho; So Yeon Park; Eun Hee Choi; Soon Koo Baik; Sang Ok Kwon; Young Ju Kim; Seung Hwan Cha; Moon Young Kim
Journal:  Clin Mol Hepatol       Date:  2015-06-26

8.  Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.

Authors:  Mee Jin Park; So Yeon Kim; Sang Min Yoon; Jong Hoon Kim; Seong Ho Park; Seung Soo Lee; Yedaun Lee; Moon-Gyu Lee
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.